Back to search
FDAFDA · Food and drugs·Recall number D-1693-2012

Fentanyl Transdermal System, 100 mcg/h, each transdermal system contains: 10 mg fentanyl and 0.4 mL alcohol USP, Rx only, supplied in single pouches (NDC 0591-3214-54 (pouch)), 5 pouches per carton (NDC 0591-3214-72 (Carton)), Manufactured by Watson laboratories Inc., Corona, CA, Distributed by: Watson, Pharma Inc.

Published October 3, 2012 · Recall initiated: July 11, 2012

Summary

FDA records drug Class II recall D-1693-2012, published October 3, 2012 and initiated July 11, 2012. Recalling firm: Actavis; Status: Terminated; Reported quantity: 98,088 cartons (5 pouches per carton); Lot: Lot number 455040A (carton) 455040 (pouch). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent; some patches may not contain fentanyl gel

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Actavis
Distributor
Nationwide
Lot
Lot number 455040A (carton) 455040 (pouch)
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fentanyl Transdermal System, 100 mcg/h, each transdermal system contains: 10 mg fentanyl and 0.4 mL alcohol USP, Rx only, supplied in single pouches (NDC 0591-3214-54 (pouch)), 5 pouches per carton (NDC 0591-3214-72 (Carton)), Manufactured by Watson laboratories Inc., Corona, CA, Distributed by: Watson, Pharma Inc. recalled?

Yes. FDA published recall D-1693-2012 on October 3, 2012. Reported hazard: Subpotent; some patches may not contain fentanyl gel

What should I do if I have this product?

Voluntary: Firm initiated · Letter